CONNECT WITH US
AI & Deeptech

AI & Deeptech

Why this new Fitbit feature takes us one step closer to non-invasive glucose tracking

ZDNET AI logo

Published on

Add as a preferred source on Google
Why this new Fitbit feature takes us one step closer to non-invasive glucose tracking

Insulin resistance and blood pressure trends are now available on two new Fitbit devices.

Google just added insulin resistance and blood pressure trends to the Fitbit Air and Edge, taking these devices beyond basic fitness monitoring and sleep tracking and into deeper health insights. The new features are part of Google’s “Health Guardian” suite of proactive safety tools for the Pixel Watch and Fitbit.

Also: Are AI health coach subscriptions a scam? My verdict after testing Fitbit’s for a month

They’re available solely for Google Health Premium users, a $100 annual subscription that grants users access to Google’s AI health coach, advanced sleep tracking, and a more expansive selection of health-tracking features.

While it doesn’t measure your insulin or glucose outright, its algorithm analyzes heart rate, activity level, sleep, and other metrics to show changes in metabolic health. The Fitbit will also track your blood pressure patterns without a cuff, monitor your pulse while you’re asleep or awake, and, at the end of the month, provide you with insights. Eligible Fitbit Air and Fitbit Edge users who have worn their device for five days or more will see this insight in the Health tab of the app.

Similar to blood pressure trends, the insulin resistance feature uses Fitbit sensors to monitor shifts in metabolic health. Insulin resistance is a precursor to type 2 diabetes, potentially giving users insight into changes in their insulin levels in a less invasive way, but pointing more toward overall trends than a direct diagnosis.


Source link
Related Topics:AI & Deeptech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.